Publications by authors named "How-Wen Ko"

Claim this Profile
P
Plasma phenylalanine is associated with hospital mortality in acute respiratory distress syndrome: a prospective metabolic profiling cohort study.
Li-Chung Chiu, Chi-Jen Lo, Chun-Ming Fan, Hsiang-Yu Tang, Tien-Ming Chan, How-Wen Ko

Eur J Med Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical β-Blocker Wet Wrap Therapy for Amivantamab-Induced Scalp and Facial Necrosis.
Hsuan-Chi Chen, Wen-Hung Chung, How-Wen Ko, Jong-Hwei Su Pang, Yu-Shien Ko

JAMA Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib.
Zi-Ting Chang, Ping-Chih Hsu, How-Wen Ko, John Wen-Cheng Chang, Chen-Te Wu

Thorac Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sesamin induces cell cycle arrest and upregulation of NKG2D ligands in MG‑63 cells and increases susceptibility to NK cell cytotoxicity.
Shou-Chu Chou, Cheng-Yi Kuo, How-Wen Ko, Pai-Tsang Huang, Chia-Hung Liu

Exp Ther Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis.
Chen-Chuan Hsu, Li-Chung Chiu, How-Wen Ko, Chiao-En Wu, Scott Chih-Hsi Kuo

Oncol Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer.
Ching-Yi Chen, How-Wen Ko, Po-Wei Hu, Cheng-Yu Chang, Chung-Yu Chen

Lung Cancer (Auckl)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class I HLA Alleles Are Associated With an Increased Risk of Osimertinib-Induced Hypersensitivity.
Chun-Bing Chen, Chuang-Wei Wang, Chun-Wei Lu, Wei-Ti Chen, Bing-Rong Zhou, How-Wen Ko

J Allergy Clin Immunol Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventilatory variables and computed tomography features in COVID-19 ARDS and non-COVID-19-related ARDS: a prospective observational cohort study.
Li-Chung Chiu, Hsin-Hsien Li, Yu-Hsiang Juan, How-Wen Ko, Scott Chih-Hsi Kuo

Eur J Med Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
Ping-Chih Hsu, Bing-Chen Wu, Chin-Chou Wang, Li-Chung Chiu, Chiung-Hsin Chang, How-Wen Ko

Vaccines (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Li-Chung Chiu, Ping-Chih Hsu, Chin-Chou Wang, How-Wen Ko, Scott Chih-Hsi Kuo

Thorac Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
Li-Chung Chiu, Chung-Shu Lee, Ping-Chih Hsu, Hsin-Hsien Li, Tien-Ming Chan, How-Wen Ko

Environ Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang, Jia-Shiuan Ju, Chi-Hsien Huang, How-Wen Ko

Ther Adv Med Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.
Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, How-Wen Ko

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Lei Nie, Ying-Nai Wang, Jung-Mao Hsu, Junwei Hou, Yu-Yi Chu, How-Wen Ko

Am J Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
Chun-Wei Lu, Jong-Hwei Su Pang, Yu-Shien Ko, Chih-Jung Chang, Chuang-Wei Wang, How-Wen Ko

J Eur Acad Dermatol Venereol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation.
How-Wen Ko, Shian-Sen Shie, Chih-Wei Wang, Chi-Tsun Chiu, Chih-Liang Wang

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.
How-Wen Ko, Chi-Tsun Chiu, Chih-Liang Wang, Tsung-Ying Yang, Chien-Ying Liu

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for Collection of Extracellular Vesicles and Their Content RNA as Liquid Biopsy for Lung Cancer Detection: Application of Differential Centrifugation and Annexin A5 Coated Beads.
Mei-Chia Wang, Guan-Yu Gong, Chih-Liang Wang, How-Wen Ko, Rong-Xuan Weng

Curr Issues Mol Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study.
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai

Ther Adv Med Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Sequencing of Circulating Cell Free DNA Can Be Used to Monitor Therapeutic Efficacy of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients.
Chiuan-Chian Chiou, Chih-Liang Wang, Ji-Dung Luo, Chien-Ying Liu, How-Wen Ko

Cancer Genomics Proteomics· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study.
Chun-Wei Lu, Ting-Ya Wang, Chi-Feng Yen, Kang-Hua Chen, Chiao-En Wu, How-Wen Ko, Yu-Shien Ko

Int J Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Lei Nie, Yongkun Wei, Fei Zhang, Yi-Hsin Hsu, Li-Chuan Chan, How-Wen Ko

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Lei Nie, Yongkun Wei, Fei Zhang, Yi-Hsin Hsu, Li-Chuan Chan, How-Wen Ko

Nat Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer.
Chih-Hsi Scott Kuo, Chin-Chou Wang, Yu-Chen Huang, Stelios Pavlidis, Chien-Ying Liu, How-Wen Ko

Thorac Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancer.
Yu-Chen Huang, Shih-Min Shen, Chien-Ying Liu, Stelios Pavlidis, Chih-Liang Wang, How-Wen Ko

Thorac Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis